BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Xu Z, Zhang Y, Dai H, Han B. Epithelial-Mesenchymal Transition-Mediated Tumor Therapeutic Resistance. Molecules 2022;27:4750. [PMID: 35897925 DOI: 10.3390/molecules27154750] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
Number Citing Articles
1 Wang Q, Huang C, Wang D, Tao Z, Zhang H, Zhao Y, Wang M, Zhou C, Xu J, Shen B, Zhu W. Gastric cancer derived mesenchymal stem cells promoted DNA repair and cisplatin resistance through up-regulating PD-L1/Rad51 in gastric cancer. Cell Signal 2023;106:110639. [PMID: 36842523 DOI: 10.1016/j.cellsig.2023.110639] [Reference Citation Analysis]
2 Deng Z, Xu Y, Cai Y, Lin W, Zhang L, Jiang A, Zhou Y, Zhao R, Zhao H, Liu Z, Yan T. Inhibition of Ribosomal RNA Processing 15 Homolog (RRP15) Suppressed Tumor Growth, Invasion and Epithelial to Mesenchymal Transition (EMT) of Colon Cancer. Int J Mol Sci 2023;24. [PMID: 36834940 DOI: 10.3390/ijms24043528] [Reference Citation Analysis]
3 Gazzillo A, Polidoro MA, Soldani C, Franceschini B, Lleo A, Donadon M. Relationship between Epithelial-to-Mesenchymal Transition and Tumor-Associated Macrophages in Colorectal Liver Metastases. Int J Mol Sci 2022;23. [PMID: 36555840 DOI: 10.3390/ijms232416197] [Reference Citation Analysis]
4 Cuyàs E, Fernández-Arroyo S, Verdura S, Lupu R, Joven J, Menendez JA. Metabolomic and Mitochondrial Fingerprinting of the Epithelial-to-Mesenchymal Transition (EMT) in Non-Tumorigenic and Tumorigenic Human Breast Cells. Cancers (Basel) 2022;14. [PMID: 36551699 DOI: 10.3390/cancers14246214] [Reference Citation Analysis]
5 Abdolahinia ED, Fathi M, Pirdel Z, Jafari S, Samiei M, Adibkia K, Sefat F, Dizaj SM, Sharifi S. Strategies to improve drug penetration into tumor microenvironment by nanoparticles: focus on nanozymes. OpenNano 2022. [DOI: 10.1016/j.onano.2022.100100] [Reference Citation Analysis]